Keren Yizhak

Dr.

    20102025

    Research activity per year

    Fingerprint

    Dive into the research topics where Keren Yizhak is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
    • 1 Similar Researchers

    Collaborations and top research areas from the last five years

    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
    • A metabolic switch to the pentose-phosphate pathway induces radiation resistance in pancreatic cancer

      Shimoni-Sebag, A., Abramovich, I., Agranovich, B., Massri, R., Stossel, C., Atias, D., Raites-Gurevich, M., Yizhak, K., Golan, T., Gottlieb, E. & Lawrence, Y. R., Jan 2025, In: Radiotherapy and Oncology. 202, 110606.

      Research output: Contribution to journalArticlepeer-review

    • Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy

      Chen, J. H., Nieman, L. T., Spurrell, M., Jorgji, V., Elmelech, L., Richieri, P., Xu, K. H., Madhu, R., Parikh, M., Zamora, I., Mehta, A., Nabel, C. S., Freeman, S. S., Pirl, J. D., Lu, C., Meador, C. B., Barth, J. L., Sakhi, M., Tang, A. L. & Sarkizova, S. & 17 others, Price, C., Fernandez, N. F., Emanuel, G., He, J., Van Raay, K., Reeves, J. W., Yizhak, K., Hofree, M., Shih, A., Sade-Feldman, M., Boland, G. M., Pelka, K., Aryee, M. J., Mino-Kenudson, M., Gainor, J. F., Korsunsky, I. & Hacohen, N., 19 Mar 2024, In: Nature Immunology. 25, 4, p. 644-658 15 p.

      Research output: Contribution to journalArticlepeer-review

    • Metabolic predictors of response to immune checkpoint blockade therapy

      Shorer, O. & Yizhak, K., 17 Nov 2023, In: iScience. 26, 11, p. 108188 108188.

      Research output: Contribution to journalArticlepeer-review

      Open Access
    • Targeting TBK1 to overcome resistance to cancer immunotherapy

      Sun, Y., Revach, O. Y., Anderson, S., Kessler, E. A., Wolfe, C. H., Jenney, A., Mills, C. E., Robitschek, E. J., Davis, T. G. R., Kim, S., Fu, A., Ma, X., Gwee, J., Tiwari, P., Du, P. P., Sindurakar, P., Tian, J., Mehta, A., Schneider, A. M. & Yizhak, K. & 39 others, Sade-Feldman, M., LaSalle, T., Sharova, T., Xie, H., Liu, S., Michaud, W. A., Saad-Beretta, R., Yates, K. B., Iracheta-Vellve, A., Spetz, J. K. E., Qin, X., Sarosiek, K. A., Zhang, G., Kim, J. W., Su, M. Y., Cicerchia, A. M., Rasmussen, M. Q., Klempner, S. J., Juric, D., Pai, S. I., Miller, D. M., Giobbie-Hurder, A., Chen, J. H., Pelka, K., Frederick, D. T., Stinson, S., Ivanova, E., Aref, A. R., Paweletz, C. P., Barbie, D. A., Sen, D. R., Fisher, D. E., Corcoran, R. B., Hacohen, N., Sorger, P. K., Flaherty, K. T., Boland, G. M., Manguso, R. T. & Jenkins, R. W., Mar 2023, In: Nature. 615, 7950, p. 158-167 10 p.

      Research output: Contribution to journalArticlepeer-review

    • Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

      Freeman, S. S., Sade-Feldman, M., Kim, J., Stewart, C., Gonye, A. L. K., Ravi, A., Arniella, M. B., Gushterova, I., LaSalle, T. J., Blaum, E. M., Yizhak, K., Frederick, D. T., Sharova, T., Leshchiner, I., Elagina, L., Spiro, O. G., Livitz, D., Rosebrock, D., Aguet, F. & Carrot-Zhang, J. & 19 others, Ha, G., Lin, Z., Chen, J. H., Barzily-Rokni, M., Hammond, M. R., Vitzthum von Eckstaedt, H. C., Blackmon, S. M., Jiao, Y. J., Gabriel, S., Lawrence, D. P., Duncan, L. M., Stemmer-Rachamimov, A. O., Wargo, J. A., Flaherty, K. T., Sullivan, R. J., Boland, G. M., Meyerson, M., Getz, G. & Hacohen, N., 15 Feb 2022, In: Cell Reports Medicine. 3, 2, p. 100500 100500.

      Research output: Contribution to journalArticlepeer-review

      Open Access